Working…
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Interviews With Older People From Turkish Origin in Belgium About Advance Care Planning

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03930823
Recruitment Status : Recruiting
First Posted : April 29, 2019
Last Update Posted : April 29, 2019
Sponsor:
Information provided by (Responsible Party):
Universitair Ziekenhuis Brussel

Brief Summary:

Advance care planning (ACP) enables individuals to define goals and preferences for future medical treatment and care, to discuss these goals and preferences with family and health-care providers, and to record and review these preferences if appropriate. Research has shown that most Western patients express the need about what ACP entails.

Ethnicity creates an important cultural impact on how people look at life and death, so that there is an influence on making decisions about end-of-life care. The Turkish ethnic group is one of the largest visible non-Western minority groups in Western countries. Studies on how ACP is perceived among patients from Turkish origin are lacking.

The objective of this study is exploring the knowledge, experiences, point of views, preferences, attitudes, facilitators and barriers concerning advance care planning of older people from Turkish origin in Belgium. Semi-structured interviews (in the native Turkish language) will be used.


Condition or disease Intervention/treatment Phase
Advance Care Planning Ethnic Minorities Turkish Origin Advance Medical Directives Muslims Living Will Other: Interview Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 30 participants
Intervention Model: Single Group Assignment
Intervention Model Description: One to one Interviews
Masking: None (Open Label)
Primary Purpose: Other
Official Title: Advance Care Planning Among Older People From Turkish Origin in Belgium: An Exploratory Interview Study
Actual Study Start Date : March 18, 2019
Estimated Primary Completion Date : December 31, 2019
Estimated Study Completion Date : March 31, 2020

Arm Intervention/treatment
Interview
One to one interviews with older people from Turkish origin in Belgium
Other: Interview
One to one interview




Primary Outcome Measures :
  1. Knowledge about advance care planning from older people from Turkish origin in Belgium [ Time Frame: 9 months ]
    This is a qualitative study. We developed a semi-structured interview guide with the following questions: What do you know in relation to advance care planning?

  2. Experiences about advance care planning from older people from Turkish origin in Belgium [ Time Frame: 9 months ]
    This is a qualitative study. We developed a semi-structured interview guide with the following questions:Have you yourself ever thought about your future healthcare? Have you yourself ever looked up something about that?

  3. Views/preferences about advance care planning from older people from Turkish origin in Belgium [ Time Frame: 9 months ]
    This is a qualitative study. We developed a semi-structured interview guide with the following questions: What do you think about discussing advance care planning now for the future? Even if you do not have such a serious illness at the moment, what are the advantages and disadvantages about discussing your wishes for the future, now?

  4. Attitudes about advance care planning from older people from Turkish origin in Belgium [ Time Frame: 9 months ]
    This is a qualitative study. We developed a semi-structured interview guide with the following questions: Before you got severe illness, do you wish to discuss to someone your future wishes in advance? Why? Do you wish to give authority on your behalf to someone? Why?

  5. Barriers and facilitators for advance care planning from older people from Turkish origin in Belgium [ Time Frame: 9 months ]
    This is a qualitative study. We developed a semi-structured interview guide with the following questions: In your opinion, what makes it easier or what would make it easier to talk about advance care planning? In your opinion, what makes it harder to talk about advance care planning?



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   65 Years and older   (Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

People:

  • with Turkish origin who live in Belgium and are older than 65 years
  • who have also given informed consent to participate in this qualitative interview study

Exclusion Criteria:

  • Patients who are terminal ill which means having a life-limiting disease with irreversible decline and expected survival in terms of months or less. (41)
  • Having cognitive impairment

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03930823


Contacts
Layout table for location contacts
Contact: Hakki Demirkapu, MD +32474873604 hakki.demirkapu@vub.be
Contact: Petra Van Den Borre +32(0)2 477 43 11 Petra.Van.Den.Borre@vub.be

Locations
Layout table for location information
Belgium
Faculteit Geneeskunde en Farmacie Recruiting
Brussels, Belgium, 1090
Contact: Hakki Demirkapu, MD    +32474873604    hakki.demirkapu@vub.be   
Contact: Petra Van Den Borre    +32(0)24774311    Petra.Van.Den.Borre@vub.be   
Sponsors and Collaborators
Universitair Ziekenhuis Brussel
Investigators
Layout table for investigator information
Principal Investigator: Hakki Demirkapu, MD Vrije Universiteit Brussel

Layout table for additonal information
Responsible Party: Universitair Ziekenhuis Brussel
ClinicalTrials.gov Identifier: NCT03930823    
Other Study ID Numbers: ACP-TR-1-2018
First Posted: April 29, 2019    Key Record Dates
Last Update Posted: April 29, 2019
Last Verified: April 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No